FDA Will Drop Two-Study Requirement for New Drug Approvals, Aiming to Speed Access U.S News February 18, 2026 ...
A policy change allowing approval of some new drugs based on one adequate and well-controlled study could accelerate ...
The FDA already authorizes the use of experimental drugs under what’s called “compassionate use,” for people with no other ...
This move is another step in Makary’s attempts to shorten FDA reviews, which started when he began his tenure last year. 3 These include mandating the use of artificial intelligence for staffers and ...
The FDA has proposed new guidelines to expedite the approval of customized treatments for rare diseases, creating a ...
The FDA has proposed new guidelines to facilitate the approval of customized treatments for rare diseases, aiming to address ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する